Legal & General Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2K | Sell |
2,557
-17,342
| -87% | -$117K | ﹤0.01% | 3071 |
|
|
2025
Q1 | $180K | Hold |
19,899
| – | – | ﹤0.01% | 2625 |
|
|
2024
Q4 | $344K | Buy |
19,899
+4,175
| +27% | +$72.2K | ﹤0.01% | 2580 |
|
|
2024
Q3 | $251K | Buy |
15,724
+876
| +6% | +$14K | ﹤0.01% | 2643 |
|
|
2024
Q2 | $212K | Buy |
14,848
+3,786
| +34% | +$54K | ﹤0.01% | 2658 |
|
|
2024
Q1 | $157K | Hold |
11,062
| – | – | ﹤0.01% | 2709 |
|
|
2023
Q4 | $167K | Hold |
11,062
| – | – | ﹤0.01% | 2722 |
|
|
2023
Q3 | $175K | Sell |
11,062
-239
| -2% | -$3.78K | ﹤0.01% | 2745 |
|
|
2023
Q2 | $171K | Buy |
11,301
+7,727
| +216% | +$117K | ﹤0.01% | 2764 |
|
|
2023
Q1 | $51.8K | Buy |
3,574
+637
| +22% | +$9.23K | ﹤0.01% | 2869 |
|
|
2022
Q4 | $39.7K | Buy |
+2,937
| New | +$39.7K | ﹤0.01% | 2979 |
|
|
2022
Q2 | – | Sell |
-848
| Closed | -$8K | – | 3654 |
|
|
2022
Q1 | $8K | Hold |
848
| – | – | ﹤0.01% | 3454 |
|
|
2021
Q4 | $15K | Buy |
+848
| New | +$15K | ﹤0.01% | 3368 |
|